U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,583 records

Showing results for "liver".
Users also searched for: hepatitis c

  1. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
    August 23, 2022 - increased risk of withdrawal because of adverse events, serious adverse events, cancer, or elevated liver … additional CHD risk factor Excluded: use of lipid-lowering therapy, intolerant of statins, significant liver

  2. Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
    August 27, 2012 - How far would we have to increase the risk of liver failure to take away that 0.84 gain in benefit from … and the answer is that patients would tolerate up to a little more than 2% increase in the chance of liver

  3. Wireless-Motility-Capsule Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
    May 01, 2013 - Am J Physiol Gastrointest Liver Physiol. 2009;297(6):G1107-14. PMID: 19808653. 49. … Am J Physiol Gastrointest Liver Physiol. 2010;299(6):G1276-86. PMID: 20847301. 65.

  4. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - Other risks of anticoagulant use include liver injury,17 minor bleeding,18 and dermatologic effects.19 … patients on DOACs, including urea and electrolytes (3 monthly to annually), full blood count, and liver … Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation

  5. THE HCUP NATIONWIDE READMISSIONS DATABASE (NRD), 2014

    hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2010-2014.jsp
    January 01, 2014 - : (1) comorbidity present, (0) comorbidity not present CM_LIVER AHRQ comorbidity measure - Liver … 17.53 2.2 15: Cancer of rectum and anus 12,496 21.26 21.68 2.0 16: Cancer of liver … 27.39 28.28 3.2 149: Biliary tract disease 107,986 14.87 15.38 3.4 151: Other liver

  6. HEALTHCARE COST AND UTILIZATION PROJECT — HCUP (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2013.pdf
    January 01, 2013 - Hypothyroidism: (1) comorbidity present, (0) comorbidity not present CM_LIVER AHRQ comorbidity measure - Liver … 37,987 17.16 17.53 2.2 15: Cancer of rectum and anus 12,496 21.26 21.68 2.0 16: Cancer of liver … abscess 8,092 27.39 28.28 3.2 149: Biliary tract disease 107,986 14.87 15.38 3.4 151: Other liver

  7. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
    May 18, 2021 - Dig Liver Dis . 2012;44(8):700-704. doi:10.1016/j.dld.2012.03.015 63. … Dig Liver Dis . 2017;49(5):557-561. doi:10.1016/j.dld.2016.12.020 114. … Dig Liver Dis . 2013;45(8):645-650. doi:10.1016/j.dld.2013.02.020 191.

  8. Organ Transplantation | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/organ-transplantation

  9. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver … Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis

  10. Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/rQBBkz9CrHh4vp7ZnEkF-t
    July 18, 2023 - Clinical importance of transient elevations in these laboratory values is unknown Low for reversible liver … Limited longer-term evidence shows few withdraw- als due to adverse events, slightly higher rates of liver

  11. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - serious adverse events (RR, 0.99 [95% CI, 0.94 to 1.04]), myalgias (RR, 0.96 [95% CI, 0.79 to 1.16]), or liver-related … increased risk of withdrawal because of adverse events, serious adverse events, cancer, or elevated liver

  12. Digestive Diseases | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/digestive-diseases

  13. Carbohydrates | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/carbohydrates

  14. Disposition of Comments for CER 162 Diagnosis of Celiac Disease (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
    January 28, 2016 - Dig Liver Dis. 2011;43:465-9.

  15. Microsoft Word - APS_DRG_Def_Public_V21.doc (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Weights%20Manual.pdf
    January 06, 2025 - Procedures Unrelated to Principal Diagnosis): Procedure code 50.29 (other destruction of lesion of liver

  16. Using the EMR to identify and screen patients at risk for delirium - Final Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/r18hs022666-weckmann-final-report-2016.pdf
    January 01, 2016 - including pain scores, body mass index; and laboratory test results (electrolytes, complete blood count, liver

  17. Final Progress Report: Incorporating Temporary Health States into Decision Support (pdf file)

    www.ahrq.gov/sites/default/files/2024-07/col-report.pdf
    January 01, 2024 - Black Cohosh Gastrointestinal pains, nausea, headaches, weight gain, constipation, liver toxicity.

  18. Final Progress Report: Evaluating e-Prescribing in a Community-Based, Integrated Health System (pdf file)

    www.ahrq.gov/sites/default/files/2024-01/devine-report.pdf
    January 01, 2024 - antihyperlipidemic medications and their corresponding laboratory values, both for safety (renal function, liver

  19. References (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/subglottic-litreview.docx
    January 01, 2017 - congestive heart failure, chronic obstructive pulmonary disease, coronary artery disease, dementia and liver

  20. Screening for Dyslipidemia in Younger Adults: A Systematic Review (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/SaASReVeD_fpHZQbeBZD5s
    October 01, 2016 - with drug treatment (e.g., myopathy, rhabdomyolysis, myalgia, cognitive loss, diabetes, elevations in liver
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

hcup-us.ahrq.gov (496)

effectivehealthcare.ahrq.gov (344)

psnet.ahrq.gov (258)

www.uspreventiveservicestaskforce.org (230)

www.ahrq.gov (175)

digital.ahrq.gov (54)

cds.ahrq.gov (15)

integrationacademy.ahrq.gov (4)

meps.ahrq.gov (4)

datatools.ahrq.gov (1)

pso.ahrq.gov (1)

qualityindicators.ahrq.gov (1)